| Elranatamab |
埃纳妥单抗 |
2408850-14-4 |
| Melrilimab |
Melrilimab |
2222865-46-3 |
| Quisovalimab |
奎索利单抗 |
2427667-03-4 |
| 1H-Purine-2,6-dione, 7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-3,7-dihydro-1,3-dimethyl-8-(1-piperazinyl)- |
TH 5427 |
2253744-56-6 |
| 4-Piperidinol, 4-(aminomethyl)-1-[5-[2-methoxy-6-(1-methylethyl)-3-pyridinyl]imidazo[2,1-b]-1,3,4-thiadiazol-2-yl]- |
化合物INE963 |
2640567-43-5 |
| (3R,5'S)-2-oxospiro[indoline-3,3'-pyrrolidine]-5'-carboxamide hydrochloride |
(3R,5'S)-2-氧代螺[吲哚啉-3,3'-吡咯烷]-5'-甲酰胺盐酸盐 |
2769953-37-7 |
| Golocdacimab |
Golocdacimab |
2418540-63-1 |
| Ifinatamab |
IFINATAMAB |
2484870-90-6 |
| Izeltabart |
Izeltabart |
2642078-60-0 |
| Inezetamab |
Inezetamab |
2568264-76-4 |
| Epacmarstobart |
Epacmarstobart |
2518200-89-8 |
| Emirodatamab |
Emirodatamab |
2449199-61-3 |
| Burfiralimab |
化合物 BURFIRALIMAB |
2460809-80-5 |
| Mevonlerbart |
Mevonlerbart |
2453195-99-6 |
| Prafnosbart |
Prafnosbart |
2566473-71-8 |
| USP25 and 28 inhibitor AZ-2 |
USP25 and 28 inhibitor AZ-2 |
2165322-95-0 |
| (S)-6-[(3,5-Dimethyl-1H-pyrazol-4-yl)methyl]-5-[(4-hydroxyisoxazolidin-2-yl)carbonyl]-1-isobutyl-3-methylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-D]嘧啶-2,4(1H,3H)-二酮 |
496791-37-8 |
| Pregabalin |
普瑞巴林 |
148553-50-8 |
| OsMundacetone |
紫萁酮 |
37079-84-8 |
| NPS 2390 |
NPS 2390 |
226878-01-9 |
QQ
微信
